TactiCath Post Market Approval Study

TactiCath Post Market Approval Study
Recruiting
18 years - 100 years
All
Phase 4
35 participants needed
1 Location

Brief description of study

The purpose of the research study is to obtain additional information safety and effectiveness of an FDA approved catheter when used to treat patients with Paroxysmal atrial fibrillation.

Detailed description of study

The purpose of the study is to provide data and safety for the Food and Drug administration (FDA). The study is designed for patients with paroxysmal atrial fibrillation. Participants will only be enrolled if at the time of consent present with paroxysmal atrial fibrillation and meet criteria for an ablation procedure. The study is seeking participants willing to be followed for a period of 5 years

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Fibrillation
  • Age: 18 years - 100 years
  • Gender: All
Updated on 19 Feb 2024. Study ID: 821652

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.